Refeeding Syndrome
Recent clinical, regulatory, research and industry developments relating to this disease.
ASPEN Consensus Recommendations for Refeeding Syndrome.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Leading journals1
- Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition1
Leading researchers8
- Adams SC1
- Ayers P1
- Berdahl GJ1
- Citty SW1
- Cober MP1
- da Silva JSV1
- Evans DC1
- Greaves JR1
Affiliations (unnormalised)6
- Akron Children's Hospital1
- Boston Children's Hospital1
- Clinical Pharmacy Services1
- College of Nursing1
- Columbia University Irving Medical Center1
- Michael E. DeBakey Veterans Affairs Medical Center1
Reference
Authoritative identity, definition & identifiers.
A condition of metabolic imbalance that is caused by complications of initially feeding a severely malnourished patient too aggressively. Usually occurring within the first 5 days of refeeding, this syndrome is characterized by WATER-ELECTROLYTE IMBALANCE; GLUCOSE INTOLERANCE; CARDIAC ARRHYTHMIAS; and DIARRHEA.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.